Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Platinum Resistant Ovarian Cancer × HMPL-013 × Gynecologic × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 3 Triple Negative Breast Neoplasms 1 Platinum Resistant Ovarian Cancer 1 Colorectal Neoplasms 1 Breast Neoplasms 1

Interventions

Sodium Chloride 1 Paclitaxel 1 HMPL-013 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06973421 2025-05-15

Phase II Study of Utidelone Plus Fruquintinib Combination Therapy for Platinum-Resistant Recurrent Ovarian Cancer

Fudan University

Phase 2 Not yet recruiting

Platinum Resistant Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡